å ¬å ±å»çã®ç·æ¥äºæ ã«å¯Ÿå¿ãã
Elsevier ã¯ãç 究è ãå»çå°é家ãæ¿çç«æ¡è ãå ¬è¡ããµããŒããããããç¹å®ã®å ¬å ±å»çã®ææ¥äºæ ã«é¢é£ããå¿ é æ å ±ããªãŒãã³ã«å©çšå¯èœã«ããŠããŸãããªãœãŒã¹ã«ã¯å€§èŠæš¡ãªå³éžããããæ»èªä»ãç 究è«æãšå»çå°é家åãã®ã¬ã€ãã©ã€ã³ãå«ãŸããŸããåŒç€ŸãªãœãŒã¹ã»ã³ã¿ãŒã®çŽè¿ã®äŸãšããŠãæ°åã³ããææçïŒCOVID-19ïŒãšãµã«çã®ã»ããéå»ã«ã»ã³ã¿ãŒã泚åãããžã«ãšãšãã©ãŠã€ã«ã¹ãæããããŸãã
ãšã«ãŒãã¢ã¯ç±³åœåœç«å»åŠå³æžé€šãšé£æºããEmergency Access Initiative(æ°ããã¿ãïŒãŠã£ã³ããŠã§éã) ãéããŠç±³åœããã³ãã®ä»ã®å°åã®ããªã±ãŒã³ã»ã€ã«ããããŒããŒãããªã¢ïŒ2017幎ïŒãã¡ãã·ã³ã®å°éïŒ2017幎ïŒè¢«çœå°ã®å»çåŸäºè ãå³æžé€šå¡ãããã³åžæ°ã«ãã«ããã¹ãèšäºãžã®äžæçãªç¡åã¢ã¯ã»ã¹ãæäŸããŸããã